𝔖 Bobbio Scriptorium
✦   LIBER   ✦

GI Hormonal Changes in Diabetes Influence Pancreatic Cancer Growth

✍ Scribed by William E. Fisher; Laszlo G. Boros; Thomas M. O'Dorisio; M.Sue O'Dorisio; William J. Schirmer

Book ID
115634803
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
318 KB
Volume
58
Category
Article
ISSN
0022-4804

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impaired growth hormone response to huma
Impaired growth hormone response to human pancreatic growth hormone releasing factor [GRF (1–44)] in type 2 (non-insulin-dependent) diabetes
✍ N. T. Richards; S. M. Wood; N. D. Christofides; S. C. Bhuttacharji; S. R. Bloom πŸ“‚ Article πŸ“… 1984 πŸ› Springer 🌐 English βš– 570 KB

Human pancreatic growth hormone releasing factor [GRF(1-44)] is the largest molecule of several peptides recently isolated from pancreatic tumours associated with acromegaly. It has been shown to stimulate the release of growth hormone in normal subjects and provides a safe and reliable tool for exa

[DLys6]-luteinizing hormone releasing ho
[DLys6]-luteinizing hormone releasing hormone–curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo
✍ S. Aggarwal; M.W. Ndinguri; R. Solipuram; N. Wakamatsu; R.P. Hammer; D. Ingram; πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 French βš– 658 KB

## Abstract Pancreatic ductal adenocarcinomas are invariably lethal, and developing effective treatments that have minimal side effects is a challenge. Previous studies from our laboratory have shown that conjugates of cell membrane disrupting lytic peptides and luteinizing hormone releasing hormon